Bayer Drops After $2 Billion Verdict in Latest Roundup Trial

Bayer AG’s shares dropped after the German conglomerate was ordered by a jury in the US state of Georgia to pay almost $2.1 billion to a plaintiff who claimed its Roundup weedkiller caused cancer, the latest setback in litigation that has already cost the company about $10 billion.

The verdict, reached late on Friday, includes $65 million in compensatory and $2 billion in punitive damages, according to an emailed statement from plaintiff law firms of Arnold & Itkin LLP and Kline & Specter PC.